$NETE 420 with CNW – Health Canada Changes Tactics in a Bid to End Cannabis Shortages

$OGRMF Cannastocks2019 Live-Stream Investor Conference & Webinar May 15th

Public Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com

NEW YORK, May 14, 2019– Virtual Investor Conferences, in partnership with Midtown Partners & Co, LLC, today announced the agenda for the upcoming Cannastocks2019 Q1 Virtual lnvestor Conference. Individual investors, institutional investors, advisors, and analysts are invited to listen and watch live. The event will feature presentations by public companies, providing insight on innovation, consolidation, international expansion and specialization in the fast-growing cannabis industry. The program opens at 9:00 AM ET on Wednesday, May 15^th.

REGISTER NOW AT: https://tinyurl.com/CannastocksVICAgenda

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There are no fees to log-in, attend the live presentations or ask questions.

May 15^th Agenda: 

Please visit www.CannaStocks2019.com for additional information.

To facilitate investor relations scheduling, for more information about the program and to view a complete calendar of Virtual Investor Conferences, please visit 
www.virtualinvestorconferences.com.

About Virtual Investor Conferences^SM
Virtual Investor Conferences is the leading proprietary investor conference series that provides an interactive forum for publicly-traded companies to meet and present directly with investors.

A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group’s suite of investor relations services specifically designed for more efficient Investor Access.  Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

View original content to download multimedia:http://www.prnewswire.com/news-releases/cannastocks2019-live-stream-investor-conference–webinar-may-15th-300849632.html

$LXRP Adds Four Members to Advisory Board, Renews Executive Contracts

• LXRP recently added multiple highly respected experts to its scientific advisory board
• The company is readying for growth by ensuring executive continuity
• LXRP continues to conduct research regarding oral nicotine

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has bolstered its future growth prospects by adding four new members to its scientific advisory board and renewing executive contracts with three-year compensation deals for key officers, including CEO Chris Bunka and President John Docherty. The agreements and new advisory board team members offer LXRP and its shareholders seamless executive continuity (http://nnw.fm/J20Ew).

New members of LXRP’s scientific advisory board include (http://nnw.fm/M65kV):

• Dr. Dwayne Godwin, dean of the graduate school and professor in the Departments of Neurobiology and Anatomy at the Institute for Regenerative Medicine at Wake Forest University;
• Dr. Terry D. Blumenthal, professor of psychology and neuroscience at Wake Forest University;
• Dr. Matthew Fraser, an associate professor and director of basic science research in the Department of Surgery, Division of Urology, at Duke University Medical Center; and
• Dr. Carla Lema Tome, an industry consultant and adjunct assistant professor of neurobiology and anatomy at Wake Forest University School of Medicine.

“Lexaria Bioscience Corp. is very pleased to welcome these accomplished experts to our Advisory Board,” Bunka stated in a news release. “[They] can provide critical scientific guidance to Lexaria’s ongoing and future R&D programs. Lexaria is building towards becoming one of the world’s leaders in drug delivery technology, and our most recent advisors can assist in achieving that goal.”

In addition, the new three-year executive agreements offer both Bunka and Docherty compensation and bonuses based on meeting certain performance criteria, as established by LXRP’s board.

Based in British Columbia, Canada, LXRP is a biotechnology company and drug-delivery platform innovator. DehydraTECH is the company’s proprietary absorption technology platform. LXRP has developed and out-licenses its disruptive technology, which promotes healthier ingestion methods and lower overall dosing. LXRP is conducting research for DehydraTECH’s potential applications for oral nicotine absorption (http://nnw.fm/OmL1K). LXRP holds a patent for oral delivery of all cannabinoids.

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://nnw.fm/LXRP

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$RIV $RIV.V Cannabis Companies Racing to Gain Exposure to CBD Beverage Market

Palm Beach, FL – May 14, 2019 – Over the last year, Canada approved cannabis.  More U.S. states are legalizing its recreational or medicinal use.  Corporate America is using CBD and hemp oil in everything from lotions and pain balm to beverages.  President Trump signed the 2018 Farm Bill into law.  Even better, according to Arcview Market Researcher and BDS Analytics, global spending on cannabis is expected to rocket 38% this year to $16.9 billion up from $12.2 billion in 2018.

Along the way, cannabis has also transformed pharmaceuticals, tobacco products, health, and wellness products.  Even the beverage market has seen a substantial impact.  For example, Constellation Brands partnered with Canopy Growth Corporation.  Molson Coors teamed with HEXO Corporation.  Even New Age Beverages is producing and distributing a new line of Marley+ CBD drinks, including Mellow Mood, a relaxation tea with CBD.  Some of the top companies in the industry include The Yield Growth Corp. (CSE:BOSS) (OTC:BOSQF), The Green Organic Dutchman (TSX:TGOD) (OTC:TGODF), Green Thumb Industries (CSE:GTII)(OTC:GTBIF), Canopy Rivers Inc. (TSX-V:RIV)(OTC:CNPOF), and Liberty Health Sciences Inc. (CSE:LHS)(OTC:LHSIF).

The Yield Growth Corp. (CSE:BOSS)(OTCQB:BOSQF) BREAKING NEWS: The Yield Growth Corp. just engaged Cornerstone Strategic Branding (CSB) to complete a visual positioning study and subsequent creation of brand and packaging design for its new hemp and cannabis beverage lines.  As Yield Growth and CSB work on these brand designs, the ownership company will be canvassing the market to secure a partner from the U.S.A. beverage industry and one multi-state operator to launch these beverages to bars and restaurants, and retail stores.

“The creation of powerful packaging and in-store communications programs is crucial for Yield Growth to successfully enter the competitive drinks market with its hemp and cannabis products,” says Penny Green, President & CEO of Yield Growth. “With CSB as an agency partner, we are confident their research, strategy and design expertise will combine with our exciting beverage options to quickly impress consumers in this market niche and generate sales throughout North America and internationally in time.  We were impressed by the effectiveness CSB has shown for its beverage sector clients such as Poland Spring 100% Natural Spring Water, Coffee Mate, Nescafe Taster’s Choice Coffee and Seagram’s Escapes under the direction of Christopher Nunes, CEO.”

Other cannabis-related developments from around the markets include:

The Green Organic Dutchman (TSX:TGOD) (OTCQX:TGODF) is developing a distribution hub for beverage and edible products for Canada and abroad.  “We believe that the beverage and edible market will be the largest single segment of the cannabis market. Cannabis, as the base ingredient, makes these products possible. The medicinal and recreational market for CBD and THC will only increase over time and starting with an organic input is the most important aspect to developing these higher margin products,” notes TGOD President Csaba Reider.

Green Thumb Industries (CSE:GTII.CN)(OTCQX:GTBIF) just announced that Rise Amherst will begin selling cannabis to adults aged 21 and over.  The store will continue to offer exceptional care to medical cannabis patients with a separate consultation space, retail floor, checkout area and exit for people with a valid Commonwealth of Massachusetts medical card. “GTI’s mission is to empower the right to wellness by progressing the responsible adult use of cannabis through innovative branded products and people-first retail experiences while remaining committed to the community,” said GTI Founder and CEO Ben Kovler.

Canopy Rivers Inc. (TSX-V:RIV.V)(OTCPK:CNPOF) just announced that its portfolio company PharmHouse Inc. entered into a second offtake agreement with Canopy Growth Corporation for the purchase of cannabis from its 1.3 million square foot greenhouse facility upon licensing. The Agreement commits an additional 20% of PharmHouse’s flowering space to Canopy Growth for the next three years, in addition to the 10% that was originally committed in May 2018. The Agreement provides for the delivery to Canopy Growth of a minimum of 25,000 kg of cannabis per year and a maximum of 45,000 kg of cannabis per year.

“PharmHouse continues to show tremendous progress at the facility, and the joint venture is quickly developing as a key pillar for value creation and synergy within the Canopy Rivers portfolio ecosystem,” said Olivier Dufourmantelle, Chief Operating Officer of Canopy Rivers. “Thanks to the collaborative contributions of our joint venture partners, the ongoing support and guidance of Canopy Rivers, and the strategic insight of Canopy Growth throughout the licensing process, we are excited to announce an incremental supply partnership that mutually benefits all three parties.”

Liberty Health Sciences Inc. (CSE:LHS.CN)(OTCQX:LHSIF) just announced that it will open its 14^th Florida dispensary in Cape Coral’s South Cape business district, subject to Florida Department of Health approval. This is the first medical facility to open in Cape Coraland Liberty’s second dispensary to open in Lee County.  The 3,380 square-foot facility includes innovative shopping displays that engage and educate patients, two private consultation rooms and a large waiting room where patients, physicians and community members can learn about the benefits of medical cannabis. The dispensary is also equipped to offer drive-through services for its patients.

“We anticipate strong patient demand in the Cape Coral area, which is supported by a large population of potential patients living in Southwest Florida who can take advantage of our exceptional customer service and educational resources,” said Victor E. Mancebo, interim CEO of Liberty. “There are many retirees living in our service area who can benefit from our products and Cape Coral is also one of the fastest growing cities in Florida. Already patients and the city of Cape Coral are embracing our presence and we are excited to provide the community with our premium medical marijuana products.”

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third- party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNM was compensated forty five hundred dollars for news coverage of the current press release issued by The Yield Growth Corp. by a non-affiliated third party.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

$LXRP 420 with CNW – China Reaps from Cannabis Industry Boom

$TGODF $TGOD Enters German CBD Market via Big New Distribution Agreement

TORONTO, May 13, 2019 – The Green Organic Dutchman Holdings Ltd. (TGOD) (TSX: TGOD) (US: TGODF) is pleased to announce that its wholly owned subsidiary, HemPoland, has entered into an agreement with Mediakos UG haftungsbeschraenkt (Mediakos) to be the exclusive distributor of CannabiGold, its premium hemp CBD brand, for the German pharmacy market.

Mediakos UG spun out of Aponeo.de, a leading German online pharmacy, and is managed by a team of seasoned industry executives with demonstrated expertise in marketing and distribution of health and wellness products. It currently distributes a broad portfolio of products to a network of more than 15,000 pharmacies and can capitalize on over 10 million customers.

“With a population of over 82 million, Germany plays a pivotal role in TGOD’s international expansion strategy,” commented Brian Athaide, CEO of TGOD. “We are thrilled to be working with Mediakos’ experienced team as we continue to solidify CannabiGold’s position as a leading brand within the European market.”

HemPoland’s CannabiGold products are now available in pharmacies across Germany as well as through their respective e-commerce platforms, including Germany’s ten largest online pharmacies.

“With CBD quickly gaining popularity in Germany, we are proud to be partnering with TGOD’s HemPoland as the exclusive distributor of their CannabiGold brand for the German pharmacy market,” stated Nikolas Primbas, CEO of Mediakos UG haftungsbeschränkt. “Their recent organic certification is an important point of differentiation which will resonate with German consumers.”

On Behalf of the Board of Directors,
The Green Organic Dutchman Holdings Ltd.

About The Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (US: TGODF) is a publicly traded, premium global organic cannabis company, with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. TGOD also has organic hemp CBD oil operations in Canada, and through its wholly owned subsidiary HemPoland distributes premium hemp CBD oil in the EU. The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned capacity of 219,000 kgs and is building 1,643,600 sq. ft. of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark.

TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.

For more information on The Green Organic Dutchman Holdings Ltd., please visit www.tgod.ca.

About Mediakos
Mediakos UG haftungsbeschränkt is a leading pharmaceutical distributor based in Germany that specializes in developing, registering, fulfilling, marketing, and positioning health related products and brands within the German pharmacy market. With its vast network and solid expertise, Mediakos has strong relationships and partnerships with some of Europe’s largest online pharmacies, as well as large distributors and wholesalers. It can capitalize on more than 10 million customers and 15,000 pharmacies.

Forward-Looking Information Cautionary Statement
This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward looking statements in this release includes, but is not limited to, statements about future distribution agreements, statements about distribution of Company products in Germany, statements about the achievement of certain certifications in connection with its facilities, statements about the receipt of any regulatory permits or licences, statements about the offering of any particular products by the Company in any jurisdiction and statements regarding the future performance of the Company. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accept responsibility for the adequacy or accuracy of this release.

$OGRMF Strengthens Leadership Team with Government Relations Expert

MONCTON, NB, May 13, 2019 – Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis is pleased to announce the recent appointment of government relations expert Cameron Bishop as the Company’s Vice President, Public Affairs and Stakeholder Relations (North America).

Mr. Bishop is a seasoned government relations expert with extensive experience working at both executive and senior levels of corporate organizations. Most recently, Mr. Bishop led governmental affairs across all levels of federal, provincial, territorial and municipal government in reform of cannabis laws and regulations at another licensed producer in Canada prior to joining Organigram. In addition, Mr. Bishop oversaw corporate engagement with advocacy groups, key opinion leaders and industry associations in developing policy positions to help create a responsible, socially minded cannabis industry in Canada. Mr. Bishop has served as co-chair of both the Legislation and Regulation Committee of the Canadian Centre of Substance Abuse’s National Advisory Council on Rx Drug Misuse and the Coalition for Responsible Cannabis Branding.

As Vice President, Public Affairs and Stakeholder Relations, Mr. Bishop will work closely with all levels of government to support Organigram’s interests supporting cannabis education, policy development and future development of improved cannabis forms and delivery mechanisms. The role will also be critical in providing strategic advice to Organigram’s leadership to further execute business plans in North America.

Prior to entering the cannabis space in 2016, Mr. Bishop’s previous experience includes leadership roles in health policy and government relations at Indivior Canada Inc., Environics Communications Inc. and the Canadian Lung Association. Mr. Bishop’s political experience includes Legislative Assistant to the Member of Parliament for Sudbury and Press Secretary to the Minister of Public Health under Prime Minister Paul Martin.

“A deep understanding of policymaking, government affairs and stakeholder engagement is crucial to developing and executing business plans in the rapidly evolving North American cannabis industry. With Cameron’s extensive knowledge and experience at both the industry and government level, he is the ideal addition to Organigram’s executive team,” says Greg Engel, Organigram CEO.

Mr. Bishop holds a Bachelor of Arts degree (high honours) in History from Carleton University. He will be based out of Organigram’s Ottawa, Ontario office.

About Organigram Holdings Inc. 

Organigram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada.

Organigram is focused on producing the highest-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the company’s global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics, Trailer Park Buds and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release contains forward-looking information.  Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved.  Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release.  Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks as disclosed in the Company’s  most recent annual information form and other Company’s documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release.  Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all.  The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. We seek safe harbor.

$TCAN Featured On BTV Broadcasted On BNN

VANCOUVER, British Columbia, May 13, 2019 — via NetworkWire – Transcanna Holdings Inc. (CSE:TCAN: XETR: TH8) (“TransCanna” or the “Company”) is pleased to announce that the Company was featured on BTV video which was broadcast this past weekend on BNN.

To view the featured broadcast, click the link below:

https://youtu.be/ph01jbkmD5c

“TransCanna continually looks for ways to communicate our initiatives with current and future shareholders. BTV represented a great opportunity for us to share our vision and build this support on a go forward basis. We will continue to use this platform as we move and be able to share our progress in Modesto,” states Jim Pakulis, CEO of TransCanna.

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at info@transcanna.com.

Media Contact
TransCanna@talkshopmedia.com
604-738-2220

On behalf of the Board of Directors

James Pakulis
Chief Executive Officer

Telephone: (604) 609-6199

The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Corporate Communications:

NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com

$VVCIF Subsidiary Expands Cannabis Product Sales to Alberta

$NETE Subsidiary Enters Partnership with $HPQ

$NUGS Praises Momentum, Expansion of Portfolio Company

• Asher House co-founders recently appeared on The Ellen Show to highlight the company’s mission of moving dogs from shelters to homes
• Sales of hemp-based Asher House Thrive Oil fund dog-adoption efforts
• Through its controlling interest in Asher House Wellness, NUGS has enabled the adoption of more than 200 dogs in North America

Cannabis Strategic Ventures Inc. (OTC: NUGS) portfolio company Asher House Wellness’ co-founders, Lee Asher and Luke Barton, recently appeared on The Ellen Show to discuss their cross-country journey to rescue sheltered animals and move them into loving homes (http://nnw.fm/VG3ep).

The two men represented the Asher House team on the broadcast, which reaches a national TV audience. The segment, titled ‘Ellen Meets Inspiring Dog Adoption Duo’, is also featured on the show’s YouTube channel. The Ellen Show currently has 31 million subscribers on…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://nnw.fm/NUGS

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$TCAN Featured in CannabisNewsAudio Broadcast

NEW YORK, May 10, 2019 — via CannabisNewsAudio — announces the TransCanna Holdings Inc. (CSE:TCAN) (XETR:TH8) availability of a CannabisNewsAudio Broadcast titled, “Full-Spectrum Seed-to-Sale Model, Quality Branding Key to Cannabis Success.”

To hear the CannabisNewsAudio version, visit:  http://cnw.fm/T6Azr

To read the full editorial, visit:  http://cnw.fm/l07RO

Last year was a year of maturation for the cannabis market. The market growth resulted from retailers in nine legal adult-use states being pushed beyond the sector’s historically core demographics, targeting fast-growing new segments such as women, with an emphasis on elements such as wellness and clearly labeled/low-dose alternatives. That trend was reinforced with CBD breaking out into the mainstream, as industrial hemp became legal throughout the United States, and cannabis companies looked for ways to stand out from the crowd.

Founded in 2017 with the goal of genuine seed-to-sale capability and rapidly acquiring a bevy of premium cannabis brands, Vancouver-based TransCanna Holdings Inc.  (CSE:TCAN) (XETR:TH8) is pursuing a true “self-contained ecosystem” approach to the sector via its California-based, wholly owned subsidiaries. TransCanna is intent on ensuring maximum brand consistency by handling every aspect of the production process — from procurement and branding and design through to distribution, transportation, marketing and sales.

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly owned California subsidiaries, to a range of industries including the cannabis marketplace. For more information, visit the company’s website at www.TransCanna.com.

About CannabisNewsWire (CNW)

CannabisNewsWire (“CNW”) is a specialized information service that (1) aggregates cannabis news, (2) provides CannabisNewsBreaks that quickly updates investors in the space, (3) enhances corporate press releases, (4) helps companies with distribution and optimization of social media, and (5) delivers comprehensive corporate communication solutions. CNW is uniquely positioned in the cannabis market with a strong team of journalists and writers who can help private and public companies reach a wide audience of investors, consumers, journalists and the general public through our ever-growing dissemination network of more than 5,000 key syndication outlets. CNW is bringing unparalleled visibility, recognition and content to the cannabis industry.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Corporate Communications:

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

$MCOA Announces Appointment of Independent Director

• Edward Manolos brings significant industry experience to the company
• Manolos opened the first medical marijuana dispensary in Los Angeles County in 2004
• Industry revenue is expected to reach $24.5 billion by 2021

Marijuana Company of America Inc. (OTCQB: MCOA), an industrial hemp company involved in the cultivation and distribution of hemp-derived products, recently announced the appointment of Edward Manolos as an independent director.

Joining the MCOA team of seasoned industry leaders, Manolos brings a wealth of knowledge and experience. In 2004, he opened the first-ever medical marijuana dispensary in Los Angeles County, and he is viewed…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to MCOA are available in the company’s newsroom at http://nnw.fm/MCOA

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$GGBXF Retail Cannabis Companies are Racing to Keep up with Demand

Palm Beach, FL – May 9, 2019 – Global spending in the retail cannabis market is expected to grow 38% in 2019 to $16.9 billion, according to analysts at Arcview Group, growing to $31.3 billion by 2022.  “Despite the speed bumps in Canada and California, the basic story line prompting an explosion of investment in the industry in 2018 remains intact,” said Tom Adams, managing director and principal analyst at BDS Analytics. “The gradual legalization around the world of a plant which humans have been happily consuming for millennia is creating one of the largest industry-growth phenomena.”

Some of the top companies in the industry include High Tide Inc. (CSE:HITI) (OTC:HITIF), Trulieve Cannabis Corporation (CSE:TRUL) (OTC:TCNNF), Green Growth Brands Inc. (CSE:GGB) (OTC:GGBXF), Westleaf Inc. (TSX-V:WL) (OTC:WSLFF) and Fire & Flower Holdings Corporation (TSX-V:FAF) (OTC:FFLWF).

High Tide Inc. (CSE:HITI) (OTCQB:HITIF) BREAKING NEWS:  High Tide just announced that it has been licensed to open their 14^th and 15^th Canna Cabana retail stores, which are located in Fort Saskatchewan, Alberta and Lacombe, Alberta.  Having met all municipal business requirements, the new stores are approved to sell smoking accessories and cannabis lifestyle products while the temporary suspension of incremental cannabis retail licensing by Alberta Gaming, Liquor and Cannabis.

The new stores continue to demonstrate High Tide’s ability to execute in the rapidly growing cannabis industry. At the moment, the company has 36 of the 37 effective maximum number of development permits established by the AGLC for retail cannabis stores across Alberta and expects to receive the one remaining development permit in the near future.

High Tide continues to advance its next 23 Alberta locations that are under various stages of development and construction. In Ontario, two Canna Cabana-branded retail cannabis locations in Hamilton and Sudbury were opened on April 20, 2019 and both are performing strongly in each market, with the next branded location in downtown Toronto expected to open on or before June 1, 2019. In Saskatchewan, the company is progressing through the last steps to complete two pending retail cannabis acquisitions. Lastly, across Alberta, British Columbia and Nova Scotia the Company has 13 Smoker’s Corner accessories shops, of which five are corporately owned and eight are franchises.   For more information and additional news for High Tide, please visit:  https://hightideinc.com/

Other cannabis-related developments from around the markets include:

Trulieve Cannabis Corporation (CSE:TRUL) (OTCPK:TCNNF) recently announced that it  signed an agreement with Colorado-based Love’s Oven, LLC to bring their edible cannabis-infused baked goods, craft concentrates, and other products to Florida’s growing patient base.  “Love’s Oven specifically crafts their products to be the highest-quality available on the market and is dedicated to helping patients achieve relief from everything from chronic pain to insomnia and other ailments. Their products are not only delicious, they’re clean, organic, and, most importantly, all natural, which is what Trulieve has focused on since the beginning,” said Trulieve CEO Kim Rivers. “Their products are an effective, reliable treatment option for patients seeking relief in innovative ways.”

Green Growth Brands Inc. (CSE:GGB) (OTCQB:GGBXF) is marketing its CBD personal care products under its Seventh Sense Brand.  The company just opened two new CBD shops in Indianapolis Indiana, and Louisville, Kentucky.  The new locations are the fourth and fifth Seventh Sense shops to open of the hundreds planned for the year.

“We are pleased with the initial performance of our shops and our eCommerce site, ShopSeventhSense.com,” said Peter Horvath, CEO of Green Growth Brands. “The investments we are making in securing premium leases and in designing beautiful shop fixtures not only create amazing consumer experiences but are fantastic marketing mechanisms for our brand. With our eventual footprint of hundreds of shops in high foot traffic locations, we will be gaining exposure to millions of potential customers.”

Westleaf Inc. (TSX-V:WL) (OTCQB:WSLFF) just exercised its previously announced to purchase all of the issued and outstanding shares of 102053592 Saskatchewan Ltd., which operates a cannabis retail store located at 170-3020 Preston Avenue, Saskatoon.  The store, which was built out as part of a license agreement with Westleaf, will operate under the Prairie Records retail banner opened for business on April 18, 2019.

“While Prairie Records creates a unique and totally different cannabis retail experience, we do want to recognize the day that activists used to bring attention to the push for legalization of cannabis which has gone on for many years,” said Adam Coates, CCO at Westleaf. “We are excited to open our doors in two Saskatoon locations providing the community with a unique retail option that celebrates the relationship between cannabis and music.”

Fire & Flower Holdings Corporation (TSX-V:FAF) (OTCPK:FFLWF) just announced that it entered into an agreement pursuant to which Fire & Flower will acquire certain assets of vendor, Prairie Sky Cannabis Inc. The Vendor currently operates four licensed retail cannabis shops in the province of Saskatchewan in the communities of Battleford, Estevan, Martensville and Moosomin, Saskatchewan under the name Jimmy’s Cannabis Shop.

“The acquisition of four additional retail cannabis stores in the province of Saskatchewan is the first in Fire & Flower’s aggressive acquisition strategy for 2019. In conjunction with our Open Fields wholesale distribution platform in the province, it cements our leadership position in this strategic market. Along with our existing portfolio of organic growth opportunities, the acquisition puts us in a good position to meet our growth goals for the year,” said Trevor Fencott, CEO of Fire & Flower.

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNM expects to be compensated twenty five hundred dollars for news coverage of the current press release issued by High Tide Inc. by a non-affiliated third party.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

$TGODF $TGOD Supply Agreement with British Columbia Liquor Distribution Branch

$GNPX Featured by NetworkNewsAudio Covering New Gene Therapies

NEW YORK, May 09, 2019  — via NetworkNewsAudio – Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio publication titled, “New Gene Therapies Hold Out Promise for Patients.”

To hear the NetworkNewsWire Audio version, visit: http://nnw.fm/D55vd

To read the full editorial, visit: http://nnw.fm/nhjN4

Gene therapies, the promising treatments pursued by companies such as Genprex Inc. (NASDAQ:GNPX), are based on turning [the] problem [of cell mutation] on its head. These therapies take genetic code, tiny snippets of biological information that tell the human body how to build itself and insert them into cells. Once in place, successful gene therapies replace damaged or missing code and help the body cure itself.

Creating these treatments is challenging work, and the companies that excel are innovators with the ability to try new approaches. Their work has won acclaim and awards, such as Genprex’s place as a finalist in the technology innovation category of the Fierce Innovation Awards.

About Genprex Inc.

Genprex Inc. is a clinical stage gene therapy company developing potentially life-changing technologies for cancer patients, based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. Oncoprex has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis, or programmed cell death, in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. Visit the company’s web site at www.genprex.com or follow Genprex on Twitter at twitter.com/genprex, Facebook at facebook.com/genprexinc, and LinkedIn at linkedin.com/company/genprex.

About NetworkNewsAudio

NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) Solution, allows you to sit back and listen to market updates, CEO interviews and a Company AudioPressRelease (APR). These audio clips provide snapshots of position, opportunity and momentum. NetworkNewsAudio (NNA) can assist your company by cutting through the overload of information in today’s market, NNA brings its clients unparalleled visibility, recognition and brand awareness. NetworkNewsWire (NNW) is where news, content and information converge. NetworkNewsWire (NNW) is a comprehensive provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW has the unparalleled ability to reach a wide audience of investors, consumers, journalists and the general public with an ever-growing distribution network of more than 5,000 key syndication outlets across the nation.

For more information, visit: www.NetworkNewsAudio.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Corporate Communications:
NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com

$RIV $RIV.V $CNPOF Significant Supply Agreement w/ PharmHouse

The 3-year contract commits 20% of PharmHouse’s cannabis production to Canopy Growth

TORONTO, May 9, 2019 – Canopy Rivers Inc. (“Canopy Rivers” or the “Company“) (TSXV: RIV) (OTC: CNPOF) is pleased to announce that its portfolio company PharmHouse Inc. (“PharmHouse“) has entered into a second offtake agreement (the “Agreement“) with Canopy Growth Corporation (“Canopy Growth“) (TSX: WEED) (NYSE: CGC) for the purchase of cannabis from its 1.3 million square foot greenhouse facility upon licensing. The Agreement commits an additional 20% of PharmHouse’s flowering space to Canopy Growth for the next three years, in addition to the 10% that was originally committed in May 2018. The Agreement provides for the delivery to Canopy Growth of a minimum of 25,000 kg of cannabis per year and a maximum of 45,000 kg of cannabis per year.

“PharmHouse continues to show tremendous progress at the facility, and the joint venture is quickly developing as a key pillar for value creation and synergy within the Canopy Rivers portfolio ecosystem,” said Olivier Dufourmantelle, Chief Operating Officer of Canopy Rivers. “Thanks to the collaborative contributions of our joint venture partners, the ongoing support and guidance of Canopy Rivers, and the strategic insight of Canopy Growth throughout the licensing process, we are excited to announce an incremental supply partnership that mutually benefits all three parties.”

This new supply arrangement provides PharmHouse with additional revenue visibility and financial de-risking for a significant portion of the expected production from the flagship facility. Canopy Rivers holds a 49% equity interest in the PharmHouse joint venture and has played an active role in sourcing and negotiating production and supply agreements, which now cover approximately 50% of expected annual output. The incremental 50% of output remains unencumbered for the development of PharmHouse’s own suite of brands and products.

“This offtake agreement represents a significant step forward for PharmHouse. By effectively committing and selling 50% of our near-term cannabis production, we favorably position PharmHouse for the development of a proprietary suite of products and brands and/or the pursuit of incremental contract manufacturing agreements,” said Tony Abbas, General Manager of PharmHouse. “The fact that we are executing yet another agreement with an industry titan like Canopy Growth sends a strong signal about the quality of our operations and the confidence in our team’s ability to deliver.”

The 1.3 million square foot facility in Leamington represents the first stage of a planned global strategic relationship between Canopy Rivers and its PharmHouse joint venture partner, a company formed by the leading principals and operators of a North American agriculture conglomerate. The parties seek to leverage their relationship networks and respective strengths in cannabis, global commercial agriculture, marketing, and distribution to pursue regulated cannabis opportunities together on a global scale.

About PharmHouse:

Formed by Canopy Rivers and a company formed by the leading principals and operators of a North American agriculture conglomerate, the PharmHouse joint venture operates out of an ultramodern 1.3 million greenhouse facility in Leamington, Ontario, constructed in 2017 using the latest in commercial agriculture technology and featuring state-of-the-art automation systems. Canopy Rivers, along with its PharmHouse joint venture partners, are actively upgrading and supplementing the facility in preparation for licensing. In January 2019, PharmHouse entered into a syndicated credit facility providing up to C$80 million of secured debt financing. PharmHouse has secured multiple offtake agreements for an aggregate 50% of the production capacity upon licensing.

About Canopy Rivers:

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers works collaboratively with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) to identify strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem.

Forward-Looking Statements

This news release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of Canopy Rivers with respect to future business activities and operating performance. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions and includes information regarding: PharmHouse’s future revenue, production and output including its own suite of brands and products; the receipt of a cultivation license by PharmHouse; PharmHouse’s continued progress and ability to create value and synergy in the Canopy Rivers ecosystem; the benefits of the Agreement for the parties thereto; the signal sent by the Agreement and the impact of the Agreement on PharmHouse’s financial risk; the favourable positioning of PharmHouse for the development of a proprietary suite of products and brands and/or the pursuit of incremental contract manufacturing agreements; the relationship between Canopy Rivers and PharmHouse and their plan to pursue opportunities on a global scale; and other expectations for economic, business and/or competitive factors.

Investors are cautioned that forward-looking information is not based on historical facts but instead reflects management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although Canopy Rivers believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of Canopy Rivers. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: regulatory and licensing risks; PharmHouse’s actual financial performance, product and brand development, production and capacity; the ability of PharmHouse to obtain a cultivation license under applicable legislation in Canada;  the ability of PharmHouse and Canopy Rivers to collaborate and for PharmHouse to contribute to the Canopy Rivers ecosystem; competition for global, regulated cannabis opportunities; changes in general economic, business and political conditions, including changes in the financial markets; the global regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; risks relating to anti-money laundering laws; compliance with extensive government regulation; public opinion and perception of the cannabis industry; and the risk factors set out in Canopy Rivers’ final short form prospectus dated February 21, 2019, filed with Canadian securities regulators and available on Canopy Rivers’ profile on SEDAR at www.sedar.com.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although Canopy Rivers has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. Canopy Rivers does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

$TCAN CBD-Infused Non-Alcoholic Beer LOI with Persuasion Brewing

VANCOUVER, British Columbia, May 09, 2019 — via NetworkWire – Transcanna Holdings Inc. (CSE:TCAN: XETR: TH8) (“TransCanna” or the “Company”) is pleased to announce the execution of a non-binding letter of intent with Persuasion Brewing Co. (“Persuasion” or “PBC”), a private brewing company located in Modesto, California.  Both companies have agreed to create a division within TransCanna’s recently purchased 196,000-square-foot vertically integrated facility (the “Facility”) to establish a Persuasion Brewing division, which will produce a variety of different CBD infusion non-alcoholic beers.  Terms of the LOI include TransCanna’s exclusive rights to the private labeled beers created at the Facility; a three-year commitment from Persuasion with a 180-day termination provision; compensation due to PBC for services rendered, which is to be determined based on a percentage of sales to dispensaries; and TransCanna to pay for the necessary equipment, including the canning and bottling lines.  Both parties agree to adhere to all local and state laws.  Completion of the transactions contemplated by the LOI remain subject to negotiation of final terms and completion of definitive documentation.

“Our 196,000-square-foot vertically integrated, cannabis-focused facility is perfectly designed to have a comprehensive bottling and canning line for multiple types of beverages. However, we firmly believe that our first beverage product subject to receipt of the appropriate licenses should be a private labeled non-alcoholic CBD-infused beer.  We believe it’s the least expensive method to generate the greatest margins as quickly as possible, and that will continue to differentiate us from others in the marketplace,” stated Jim Pakulis, CEO of TransCanna.

“The few companies in California that are currently in the non-alcoholic CBD-infused sector, based on my personal research, have done extremely well financially,” stated Chad Swan, president of Persuasion Brewing Co. “TransCanna is supplying the facility, capital, software, distribution and marketing platform, and we’ll supply the intellectual property and knowhow to create a superb CBD-infused non-alcoholic beer.  We currently have 16 various styles of beer on tap or in kegs, so to expand into this market is a natural fit.  And the fact that the brewery is only a five-minute drive to TransCanna’s facility makes the logistics of moving equipment and staffing streamlined.”

The owner of Persuasion, Chad Swan, was a principal of the company that owned the Facility recently purchased by TransCanna.  As previously reported, Mr. Swan’s company that owned the facility received 1.2 million warrants at US$2.60 and 500,000 restricted shares of TransCanna.

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at info@transcanna.com.

On behalf of the Board of Directors

James Pakulis
Chief Executive Officer

Telephone: (604) 609-6199

The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Forward-looking statements in this news release include, but are not limited to:  the potential terms of the transaction, the ability of the Company to complete the transactions contemplated by the LOI and the receipt of necessary permitting. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Corporate Communications:
NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com

$GGBXF to Sell Hemp CBD Products in Select Abercrombie & Fitch Locations

$TGODF $TGOD Enters US Market Through Cornerstone Investment in Califormulations

TORONTO, May 8, 2019 – The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX:TGOD) (US:TGODF) is pleased to announce the Company’s strategic investment into the US beverage space as a co-founding investor and strategic partner in the newly formed Califormulations LLC (“Califormulations”). Califormulations will operate out of Columbus, Georgia serving global branded companies with concept-to-shelf beverage commercialization support including formulation development, technical services, in-house pilot scale production and contract manufacturing co-ordination. TGOD will work with Califormulations to expedite the US launch of TGOD branded organic hemp-based CBD beverages, as local laws and regulations permit.

“We are incredibly excited to partner with Califormulations to further our development of hemp-based CBD beverage products,” said Brian Athaide, CEO of TGOD. “With the US market for functional beverages, including wellness, energy and sport recovery, currently worth over USD$20 billion, we want to remain on the cutting edge of innovation and establish the foundation for future proprietary and novel TGOD-branded products. TGOD strives to partner with established industry leaders, and we believe that this forward-looking strategic partnership positions TGOD to capitalize on the future cannabinoid beverage market.”

Califormulations is well positioned to immediately execute on a strategy to become the preeminent beverage formulation and commercialization centre in the United States.  TGOD’s co-founding investment in Califormulations is occurring alongside the expertise of Symrise Inc. (“Symrise”), including its Beverage Innovation Centers in Laguna Beach and Teterboro. Symrise, TGOD and founding management have provided a combination of equity and debt financing to capitalize Califormulations.

TGOD’s investment in Califormulations illustrates TGOD’s progressive corporate philosophy of investing in brand differentiating capabilities.  As global laws and regulations permit, Califormulations will be an important enabler allowing TGOD to manage supply chains without excessive investment in bricks and mortar.  This approach is consistent with TGOD’s long-term objective to focus capital investments on building the world’s leading organic cannabis brand. The Company intends to leverage the experience within Califormulations to expedite the US launch of TGOD-branded organic hemp-based CBD beverages, as laws and regulations permit. Initially, however, the focus will be on having bulk non-infused beverage concentrates produced and shipped by Califormulations to TGOD-owned and contracted manufacturing sites around the globe, including Canada, for infusion with cannabinoids and distribution within legal markets.

Califormulations is a key component to TGOD’s existing global organic cannabinoid-infused beverage strategy. TGOD’s beverage team will have access to and use of Califormulations’ R&D facilities to collaborate on hemp-derived CBD beverage developments, while maintaining and enhancing TGOD’s intellectual property portfolio. TGOD will enjoy certain exclusivities pertaining to the development of organic cannabinoid-infused beverages through the Califormulations platform.

“Collectively, the complementary capabilities of this ecosystem give Califormulations a unique position in the beverage/consumer packaged goods market that will foster innovation and scale new, successful brands quickly,” commented Paul Graham, President of Symrise Flavors North America.

On Behalf of the Board of Directors,
The Green Organic Dutchman Holdings Ltd.

About The Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (US: TGODF) is a publicly traded, premium global organic cannabis company, with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. TGOD also has organic hemp CBD oil operations in Canada, and through its wholly owned subsidiary HemPoland distributes premium hemp CBD oil in the EU. The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned capacity of 219,000 kgs and is building 1,643,600 sq. ft. of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark.

TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.

For more information on The Green Organic Dutchman Holdings Ltd., please visit www.tgod.ca.

About Symrise
Symrise is a global supplier of fragrances, flavorings, cosmetic active ingredients and raw materials, as well as functional ingredients. Its clients include manufacturers of perfumes, cosmetics, food and beverages, the pharmaceutical industry and producers of nutritional supplements and pet food.

Its sales of approximately € 3.2 billion in the 2018 fiscal year make Symrise a leading global provider. Headquartered in Holzminden, Germany, the Group is represented with over 100 sites in Europe, Africa, the Middle East, Asia, the United States and Latin America.

Symrise works with its clients to develop new ideas and market-ready concepts for products that form an indispensable part of everyday life. Economic success and corporate responsibility are inextricably linked as part of this process. Symrise – always inspiring more …

www.symrise.com

Forward-Looking Information Cautionary Statement
This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward looking statements in this release includes, but is not limited to, statements about the development of Califormulations’ business, the development of future TGOD-branded products including organic hemp-based CBD-based beverages, the development and distribution of cannabinoid infused beverages in Canada and elsewhere, the development of TGOD’s organic cannabis brands, statements about future facility construction, statements about the achievement of certain certifications in connection with its facilities, collaboration between TGOD’s beverage team and Califormulations, and statements regarding the future performance of the Company. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accept responsibility for the adequacy or accuracy of this release.

$TCAN Provides Video Tour of 196,000 Sq. Ft. Vertically Integrated Facility

VANCOUVER, British Columbia, May 08, 2019 — via NetworkWire – Transcanna Holdings Inc. (CSE:TCAN: XETR: TH8) (“TransCanna” or the “Company”) is pleased to provide its shareholders and investors with an eight-minute video presented by its CEO, Jim Pakulis, as he describes the features and benefits of the acquisition of the 196,000-square-foot vertically integrated cannabis-focused facility.

“The TransCanna property is significant and takes in excess of 90 minutes for the complete tour. Our goal was to provide a glimpse of the size and scope of the facility through this video, which we believe will allow us to scale as we create and acquire 15 premium brands in California. Our objective is to grow TransCanna as expeditiously as possible, and we believe this facility is a huge step forward in achieving that goal,” stated Jim Pakulis.

Video Link: https://youtu.be/CbZz_yZQ4nE

Shortly the company will be providing an update on our senior management search as we build out the team to oversee all operations of the multifaceted facility. We’ve been looking for individuals with deep knowledge of the cannabis or agriculture environment with experience in operating a large-scale revenue generating facility. The candidates are outstanding and we’re extremely excited to be making announcements as they materialize.

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at info@transcanna.com.

On behalf of the Board of Directors

James Pakulis
Chief Executive Officer

Telephone: (604) 609-6199

The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Forward-looking statements in this news release include, but are not limited to: the size and terms of the Offering, the Closing Date and the ability of the Company to complete the Offering and the proposed use of proceeds therefrom. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Corporate Communications:
NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com

$LXRP CBD-Beverage Formulation License Agreement with Nevada-Based Company

Kelowna, British Columbia / May 7, 2019 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces that it has entered a definitive 5-year agreement, via its subsidiary Lexaria Hemp Corp, to provide Lexaria’s patented DehydraTECHTM technology to a private Nevada-based company for its utilization in certain CBD-based beverages to be produced and sold across the USA.

Financial terms of the agreement are not being disclosed. The DehydraTECH-enabled beverages are protected under Lexaria’s many existing US-granted patents and may include any combination of ready-to-drink beverages such as non-alcoholic beers, wines and spirits; cold or hot coffee or teas, sports drinks and more.

Lexaria has developed methods of combining nano-emulsion technology with its proprietary DehydraTECH processes to create beverages with market-leading aesthetic and performance characteristics. Lexaria continues to experience strong demand in North American markets for use of its technology for beverage applications.

Lexaria also announces the granting of 790,000 stock options valid for five years, to directors, an officer and employees of the Company, bearing an exercise price of US$0.99. The options will vest as to 510,00 immediately; 60,000 on November 26, 2019; 50,000 on April 15, 2020; 60,000 on November 26, 2020; 50,000 on April 15, 2021; and, 60,000 on November 26, 2021.

The options are being issued pursuant to Lexaria’s Equity Incentive Plan (the “Plan”), as approved by its board of directors of May 1, 2019 and will be subject to a four month hold period from the date of issue, pursuant to Canadian Securities Exchange policy. The Plan is expected to be registered with the United States Securities and Exchange Commission.

The securities referred to herein have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Lexaria

Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECH(TM) delivery technology. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs),nicotine and other molecules.

www.lexariabioscience.com

For regular updates, connect with Lexaria on Twitter https://twitter.com/lexariacorp

and on Facebook https://www.facebook.com/lexariabioscience/

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Bioscience Corp.

Alex Blanchard, Communications Manager

(250)765-6424 Ext 202

Or

NetworkNewsWire (NNW)

www.NetworkNewsWire.com

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements, including but not limited to: that any additional stock warrants or stock options will be exercised. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition, the patent application and approval process and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that existing capital is sufficient for the Company’s needs or that it will be able to raise additional capital. There is no assurance that Lexaria will successfully complete any other contemplated or existing technology license agreements; or that results from any studies will be favorable or in any way support future business activities of any kind. Scientific R&D is often unpredictable and unanticipated results could emerge from any study and have a material impact. There is no assurance that any planned corporate activity, scientific study, R&D, business venture, or initiative will be pursued, or if pursued, will be successful. There is no assurance that any of Lexaria’s postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA). TurboCBDTM, DehydraTECHTM technology and ViPovaTM products are not intended to diagnose, treat, cure or prevent any disease.

$GGBXF Brings Hemp CBD to Abercrombie And Fitch

Cannabis company Green Growth Brands Inc. (CSE:GGB) (OTC:GGBXF) (“GGB” or “the Company”) is partnering with Abercrombie & Fitch Co. to sell its CBD-infused bath bombs and other body-care products in a limited number of stores.

Columbus, Ohio-based Green Growth already sells personal-care products containing the non-intoxicating ingredient at DSW shoe stores, has CBD shops in malls owned by Simon Property Group Inc. and has a licensing agreement with Authentic Brands Group and its Greg Norman brand.

The deal, announced Tuesday, will see Seventh Sense Botanical Therapy body scrubs, bath bombs, cleansing oils, lotions and lip balms sold in 10 Abercrombie & Fitch stores in Massachusetts, California, Colorado, and Nevada. The products are made with CBD derived from hemp, which was legalized with the U.S. farm bill in December and is said by its proponents to help with health issues ranging from insomnia to pain and inflammation.

Green Growth appointed Brian Logan, a former executive at New Albany, Ohio-based Abercrombie, as its chief financial officer earlier this year.

Green Growth Brands Inc. (CSE:GGB) (OTC:GGBXF) recently walked away from a takeover bid for Canadian pot company Aphria Inc. after Aphria’s shares traded significantly above the offer price. The two companies are now in discussions about a potential commercial arrangement, they said last month.

Please See Disclaimer

$TGODF $TGOD to Release First Quarter 2019 Earnings

The Green Organic Dutchman Holdings Ltd. (“TGOD” or the “Company”) (TSX: TGOD) (US: TGODF) announced today that the Company expects to release its first quarter 2019 earnings on Wednesday, May 14, 2019, after market close. The Company will hold a conference call conducted by Brian Athaide, Chief Executive Officer, and Sean Bovingdon, Chief Financial Officer, at 9:00 am Eastern Time on May 15, 2019, to discuss first quarter 2019 results and future outlook.

CONFERENCE CALL INFORMATION:

Date: May 15, 2019 | Time: 9:00 am EST

Participant Dial-In

Local – Toronto: 416 – 764 – 8688

Toll Free – North America: 1- 888- 390 – 0546

Conference ID – 42408893

Listen to Webcast

https://event.on24.com/wcc/r/2000560/A41E1009460930B4049B2D2E19CCCFED

Replay Dial-In

Local – Toronto: 416-764-8677

Toll Free – North America: 1-888-390-0541

Replay Passcode: 408893# [Available until Wednesday, May 22^nd, 2019]

On Behalf of the Board of Directors,
The Green Organic Dutchman Holdings Ltd.

About The Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (US: TGODF) is a publicly traded, premium global organic cannabis company, with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. TGOD also has organic hemp CBD oil operations in Canada, and through its wholly owned subsidiary HemPoland distributes premium hemp CBD oil in the EU. The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned capacity of 219,000 kgs and is building 1,643,600 sq. ft. of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark.

TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.

For more information on The Green Organic Dutchman Holdings Ltd., please visit www.tgod.ca.

$TCAN 420 with CNW – NH Senate Okays Medical Marijuana Home Cultivation

$GNPX New Gene Therapies Hold Out Promise for Patients

$TGODF $TGOD Receives Prestigious Awards

$YGYI CLR Roaster’s Announces Multi Chain Expansion

SAN DIEGO, May 6, 2019 — Youngevity International, Inc. (NASDAQ: YGYI), a leading multi-channel lifestyle company, announced the expansion of its Josies Java House™ Brand into 570 retail doors throughout Southeastern Grocers.  The new distribution footprint now includes 400 Winn Dixie stores, 96 Bi-Lo stores, 25 Fresco Y Mas stores, and 50 Harvey stores.  The new program comes on the heels of the successful promotion of the company’s espresso brands Café La Rica and Café Cachita which is now available in Florida, Georgia, Alabama, Louisiana, Mississippi, and North and South Carolina.  Josies Java House consists of a variety of flavor profiles available in single serve format that is compatible with the Keurig^™ Brewers and other popular single serve brewing machines.

“We are very excited to see our Josies Java House Brand adding to our successful partnership with Southeastern Grocers.  Our multi-brand strategy continues to develop a stronger footprint at retail,” stated Ernesto Aguila, President of CLR, and Founder of the CLR Roasters.  “We are quite enthusiastic to see growth taking place with our single serve Josies Java House Brand as this is a major focus for our company this year.”

Dave Briskie, President and CFO, of YGYI, the parent company that owns CLR Roasters, stated, “Our Coffee Division is off to a fast start this year.  We are seeing strong growth within our green coffee distribution as well as growth within our roasted coffee division including our company owed brands.  We look forward to seeing Josies Java House becoming available in all Southeastern Grocers locations with a planned on shelf date of Q4 of this year.”

About CLR Roaster

Youngevity’s coffee manufacturing division, CLR Roasters, was established in 2001 and is a wholly-owned subsidiary. CLR Roasters is a full-sized coffee roaster that produces gourmet coffees under its own boutique brands — Café La Rica®, Josie’s Java House®, and Javalution®; manufactures a variety of private labels for major national chains; and for the direct selling channel under Youngevity International. The company remains one of the largest suppliers in North America to the cruise line industry. CLR was the first entrant into the fortified coffee niche with its Youngevity JavaFit® brand. In May 2014, CLR acquired a coffee plantation and processing facility in Nicaragua, allowing the entity to control coffee production and quality — from field to cup.

About Youngevity International, Inc.

Youngevity International, Inc. ( NASDAQ : YGYI ), is a multi-channel lifestyle company operating in 3 distinct business segments including a commercial coffee enterprise, a commercial hemp enterprise, and a multi-vertical omni direct selling enterprise. The Company features a multi country selling network and has assembled a virtual Main Street of products and services under one corporate entity, YGYI offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, as well as innovative services. For investor information, please visit YGYI.com. Be sure to like us on Facebook and follow us on Twitter.

Safe Harbor Statement

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, forward-looking statements can be identified by terminology such as “may,” “should,” “potential,” “continue,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” and similar expressions, and include statements regarding Josies Java House becoming available in all Southeastern Grocers locations with a planned on shelf date of Q4 of this year. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release and are subject to a number of risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others,  our ability to  expand into all Southeastern Grocers locations by Q4 of this year, our ability to continue our coffee segment growth, our ability to continue our international growth, our ability to leverage our platform and global infrastructure to drive organic growth, our ability to improve our profitability, expand our liquidity, and strengthen our balance sheet, our ability to continue to maintain compliance with the NASDAQ requirements, the acceptance of the omni-direct approach by our customers, our ability to expand our distribution,  our ability to continue our financial performance and the other factors discussed in our Annual Report on Form 10-K for the year ended December 31, 2018 and our subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

All product names referenced herein are trademarks of their respective companies.

Contacts:

Youngevity International, Inc.
Dave Briskie
President and Chief Financial Officer
1 800 982 3189 X6500

Investor Relations
YGYI investor relations
800.504.8650
investors@ygyi.com

Media Contact
Dwain Schenck
Schenck Strategies
203-223-5230 
dwain@schenckstrategies.com

$TCAN Appoints Haywood Securities as Lead Agent on $10M Brokered Private Placement

$LXRP Enters New Licensing Agreement, Strengthens Business Model

• Lexaria continues to create a strong, revenue-generating business model to support its growing patent portfolio
• The company out-licenses disruptive delivery technology, giving licensees access to existing patents
• Lexaria entered into a new beverage license agreement with a California-based cannabis firm
• The company recently announced four new appointments to its scientific advisory board

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a drug-delivery platform innovator with existing cannabinoid licensing agreements in Canada and the United States, as well as internationally. By out-licensing disruptive delivery technology DehydraTECH, the company has created a strong, revenue-generating business model and a growing patent portfolio.

At the end of 2018, LXRP held 10 granted patents, with 53 patent applications filed and pending in more than 40 countries around the world. The company is unique in that it is the only…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://nnw.fm/LXRP

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com